Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Topical Ruxolitinib in Acute Skin GVHD: A Pilot Study

NCT07801248 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT07801248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07801248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Topical Ruxolitinib in Acute Skin GVHD: A Pilot Study
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 31, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute skin graft versus host disease (gvhd)